Goserelin acetate (JAN/USP)

Goserelin acetate (JAN/USP) Brand names, Goserelin acetate (JAN/USP) Analogs

Goserelin acetate (JAN/USP) Brand Names Mixture

Fluoracaine Oph Soln (Fluorescein Sodium + Proxymetacain Hcl)
Fluorescein Sodium & Benoxinate Hydrochloride Ophtalmic Solution, Usp (Benoxinate Hydrochloride + Fluorescein Sodium)
Fluress (Benoxinate Hydrochloride + Fluorescein Sodium)
Fluress Liq Oph (Benoxinate Hydrochloride + Fluorescein Sodium)

Goserelin acetate (JAN/USP) Chemical_Formula

C₅₉H₈₄N₁₈O₁₄

Goserelin acetate (JAN/USP) RX_link

http://www.rxlist.com/cgi/generic/goserel.htm

Goserelin acetate (JAN/USP) fda sheet

Goserelin_acetate_(JAN/USP) FDA

Goserelin acetate (JAN/USP) msds (material safety sheet)

Goserelin acetate (JAN/USP) Synthesis Reference

Weber et al., U.S. Pat. 3,454,635 (1969)

Goserelin acetate (JAN/USP) Molecular Weight

1269.41 g/mol

Goserelin acetate (JAN/USP) Melting Point

No information avaliable

Goserelin acetate (JAN/USP) H₂O Solubility

Soluble

Goserelin acetate (JAN/USP) State

Solid

Goserelin acetate (JAN/USP) LogP

-2.517

Goserelin acetate (JAN/USP) Dosage Forms

Supplied as a sterile and totally biodegradable d,l-lactic and glycolic acids copolymer (13.3-14.3 mg/dose) impregnated with goserelin acetate equivalent to 3.6 mg of goserelin in a disposable syringe device fitted with a 16-gauge hypodermic needle

Goserelin acetate (JAN/USP) Indication

Breast cancer; Prostate carcinoma; Endometriosis

Goserelin acetate (JAN/USP) Pharmacology

The pharmacokinetics of ZOLADEX have been determined in both male and female healthy volunteers and patients. In these studies, ZOLADEX was administered as a single 250µg (aqueous solution) dose and as a single or multiple 3.6 mg depot dose by subcutaneous route.

Goserelin acetate (JAN/USP) Absorption

Inactive orally, rapidly absorbed following subcutaneous administration

Goserelin acetate (JAN/USP) side effects and Toxicity

No experience of overdosage from clinical trials

Goserelin acetate (JAN/USP) Patient Information

BIOD00113.html

Goserelin acetate (JAN/USP) Organisms Affected

Humans and other mammals